Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets

July 30, 2008

In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.

Their breakthrough research, featured as the cover story in a recent issue of Molecular Cell, describes the precise molecular and biochemical structure of drug targets known as neurotransmitter-sodium symporters (NSSs), and how cells use them to enable neural signaling in the brain. A second study, published in the latest issue of Nature Neuroscience, pinpoints where the drug molecules bind in the neurotransmitter transporter - their target in the human nervous system.

"These findings are so clear and detailed at the level of molecular behavior that they will be most valuable to developing more effective therapies for mood disorders and neurologic and psychiatric diseases, and to direct effective treatments for drug addiction to cocaine and amphetamines," says co-lead author Dr. Harel Weinstein, Chairman and Maxwell M. Upson Professor of Physiology and Biophysics, and director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al-saud Institute for Computational Biomedicine at Weill Cornell Medical College. "This research may also open the door to the development of new therapies for dopamine-neurotransmitter disorders such as Parkinson's disease, schizophrenia, and anxiety and depression."

To make their observations, the research team led by Dr. Jonathan Javitch, senior author of the Molecular Cell study and contributing author to the Nature Neuroscience study, and professor of Psychiatry and Pharmacology in the Center for Molecular Recognition at Columbia University Medical Center, stabilized different structural states of the neurotransmitter-sodium-symporter molecule that relate to steps in its function. This allowed the team to study how substrates and inhibitors affect the transition between these different states, and thus to understand the way in which its function is accomplished.

"Crystallography had allowed the identification of only one structural form of the molecule, but our experiments and computations were able to identify how this form changes and thereby add an understanding of the functional role of the different forms that the molecule must adopt to accomplish transport activity," says Dr. Javitch.

The main surprise was the realization that two binding sites on the transporter molecule need to be filled simultaneously and cooperate in order for transport to be driven across the cell membrane. For these studies, the scientists used the crystal structure of a bacterial transporter that is very similar to human neurotransmitter transporters. They performed computer simulations to reveal the path of the transported molecules into cells. Laboratory experimentation was used to test the computational predictions and validate the researchers' inferences.

Together, these procedures revealed a finely-tuned process in which two sodium ions bind and stabilize the transporter molecule for the correct positioning of the two messenger molecules - one deep in the center of the protein, and the other closer to the entrance. Like a key engaging a lock mechanism, this second binding causes changes in the transporter throughout the structure, allowing one of the two sodium molecules to move inward, and then release the deeply bound messenger and its sodium partner into the cell.

In the bacterial transporter studied, antidepressant molecules bind in the outer one of two sites, and stop the transport mechanism, leaving the messenger molecule outside the cell.

The second team of researchers, involving a collaboration of the Weinstein and Javitch labs with colleagues in Denmark (the labs of Ulrik Gether and Claus Loland), found that in the human dopamine transporter cocaine binds in the deep site, unlike the antidepressant binding in the bacterial transporter. Therefore, the researchers conclude that anti-cocaine therapy will be more complicated, because interfering with cocaine binding also means interference with the binding of natural messengers.

"This finding might steer anti-cocaine therapy in a completely new direction," says Dr. Weinstein.

Molecular understanding at this level of structural and dynamic detail is rare in the world of drug development, the authors note. Only about 15 percent of all drugs have a known molecular method-of-action, even though the effects of these drugs within the body - after very stringent and controlled laboratory testing - are well understood pharmacologically.

Contributing authors to the Molecular Cell study include Dr. Lei Shi from Weill Cornell Medical College, who had a major role in the computational simulations; Dr. Matthias Quick from Columbia University Medical Center and the New York State Psychiatric Institute, who had a major role in the experimental component; and Dr. Yongfang Zhao from Columbia University Medical Center.

Lead authors of the Nature Neuroscience study are first author Dr. Thijs Beuming of Weill Cornell Medical College and senior authors Drs. Claus Loland and Ulrik Gether of The Panum Institute of the University of Copenhagen, Denmark. Additional co-authors include Drs. Julie Kniazeff, Marianne Bergmann and Klaudia Raniszewska of The Panum Institute of the University of Copenhagen; Drs. Lei Shi and Luis Gracia of Weill Cornell; and Dr. Amy Hauck Newman of the National Institute on Drug Abuse (NIDA).

The NIH supported these studies, and it is noteworthy that both the Molecular Cell and the Nature Neuroscience study share an NIH funding source, a Program Project grant awarded by the National Institute on Drug Abuse and directed by Dr. Weinstein, with Drs. Javitch and Gether each directing one of the projects. Additional support came from the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation and the Maersk Foundation - all in Europe.

Weill Cornell Medical College




Cocaine: An Unauthorized Biography

Cocaine: An Unauthorized Biography
by Dominic Streatfeild (Author)


The story of cocaine isn’t just about crime and profit; it’s about psychoanalysis, about empire building, about exploitation, emancipation, and, ultimately, about power. To tell the story of the twentieth century without reference to this drug and its contribution is to miss a vital and fascinating strand of social history. Streatfeild examines the story of cocaine from its first medical uses to the worldwide chaos it causes today. His research takes him from the arcane reaches of the British Library to the isolation cells of America’s most secure prisons; from the crackhouses of New York to the jungles of Bolivia and Colombia.


Kings of Cocaine

Kings of Cocaine
by Guy Gugliotta (Author), Jeff Leen (Author)


This is the story of the most successful cocaine dealers in the world: Pablo Escobar Gaviria, Jorge Luis Ochoa Vasquez, Carlos Lehder Rivas and Jose Gonzalo Rodriguez Gacha. In the 1980s they controlled more than fifty percent of the cocaine flowing into the United States. The cocaine trade is capitalism on overdrive -- supply meeting demand on exponential levels. Here you'll find the story of how the modern cocaine business started and how it turned a rag tag group of hippies and sociopaths into regal kings as they stumbled from small-time suitcase smuggling to levels of unimaginable sophistication and daring. The $2 billion dollar system eventually became so complex that it required the manipulation of world leaders, corruption of revolutionary movements and the worst kind of violence...

Cocaine, Death Squads, and the War on Terror: U.S. Imperialism and Class Struggle in Colombia

Cocaine, Death Squads, and the War on Terror: U.S. Imperialism and Class Struggle in Colombia
by Oliver Villar (Author), Drew Cottle (Author)


Since the late 1990s, the United States has funneled billions of dollars in aid to Colombia, ostensibly to combat the illicit drug trade and State Department-designated terrorist groups. The result has been a spiral of violence that continues to take lives and destabilize Colombian society. This book asks an obvious question: are the official reasons given for the wars on drugs and terror in Colombia plausible, or are there other, deeper factors at work? Scholars Villar and Cottle suggest that the answers lie in a close examination of the cocaine trade, particularly its class dimensions. Their analysis reveals that this trade has fueled extensive economic growth and led to the development of a "narco-state" under the control of a "narco-bourgeoisie" which is not interested in eradicating...

The Crack Cocaine Diet

The Crack Cocaine Diet
by HarperCollins e-books


New York Times bestselling author Laura Lippman has been hailed as one of the best crime fiction writers in America today, winning virtually every major award in the genre. The author of the enormously popular series featuring Baltimore P.I. Tess Monaghan as well as three critically lauded stand-alone novels, Lippman now turns her attention to short stories—and reveals another level of mastery.Lippman sets many of the stories in this sterling anthology, Hardly Knew Her, in familiar territory: her beloved Baltimore, from downtown to its affluent suburbs, where successful businessmen go to shocking lengths to protect what they have or ruthlessly expand their holdings, while dissatisfied wives find murderous ways to escape their lives. But Lippman is also unafraid to travel—to New...

Andean Cocaine: The Making of a Global Drug

Andean Cocaine: The Making of a Global Drug
by Paul Gootenberg (Author)


Illuminating a hidden and fascinating chapter in the history of globalization, Paul Gootenberg chronicles the rise of one of the most spectacular and now illegal Latin American exports: cocaine. Gootenberg traces cocaine's history from its origins as a medical commodity in the nineteenth century to its repression during the early twentieth century and its dramatic reemergence as an illicit good after World War II. Connecting the story of the drug's transformations is a host of people, products, and processes: Sigmund Freud, Coca-Cola, and Pablo Escobar all make appearances, exemplifying the global influences that have shaped the history of cocaine. But Gootenberg decenters the familiar story to uncover the roles played by hitherto obscure but vital Andean actors as well--for example, the...

Doctor Dealer: The Rise and Fall of an All-American Boy and His Multimillion-Dollar Cocaine Empire

Doctor Dealer: The Rise and Fall of an All-American Boy and His Multimillion-Dollar Cocaine Empire
by Mark Bowden (Author)


Doctor Dealer is the story of Larry Lavin, a bright, charismatic young man who rose from his working-class upbringing to win a scholarship to a prestigious boarding school, earn Ivy League college and dental degrees, and buy his family a house in one of Philadelphia's most exclusive suburbs. But behind the facade of his success was a dark secret -- at every step of the way he was building the foundation for a cocaine empire that would grow to generate over $60 million in annual sales. Award-winning journalist Mark Bowden tells the saga of Lavin's rise and fall with the gripping, novelistic narrative style that won him international acclaim as the author of the New York Times best-seller Black Hawk Down. "Immensely readable . . . eye-popping . . . a smoothly crafted, exciting,...

An Anatomy of Addiction: Sigmund Freud, William Halsted, and the Miracle Drug Cocaine

An Anatomy of Addiction: Sigmund Freud, William Halsted, and the Miracle Drug Cocaine
by Howard Markel (Author)


From acclaimed medical historian Howard Markel, author of When Germs Travel, the astonishing account of the years-long cocaine use of Sigmund Freud, young, ambitious neurologist, and William Halsted, the equally young, pathfinding surgeon. Markel writes of the physical and emotional damage caused by the then-heralded wonder drug, and how each man ultimately changed the world in spite of it—or because of it. One became the father of psychoanalysis; the other, of modern surgery.
 
Both men were practicing medicine at the same time in the 1880s: Freud at the Vienna General Hospital, Halsted at New York’s Bellevue Hospital. Markel writes that Freud began to experiment with cocaine as a way of studying its therapeutic uses—as an antidote for the overprescribed morphine, which had...

The Pleasures of Cocaine

The Pleasures of Cocaine
by Adam Gottlieb (Author)


The Pleasures of Cocaine conveys the impartial facts of the uses and abuses of cocaine. Without bias, many different aspects are covered:

History, effects, uses, pleasures, dangers
Avoiding abusive side effects
Determining quality
Substances used to cut coke and thier effects
Testing for purity and removing impurities
Improving appearance
Inside look at dealing
Cultivation of coca plants
Coca leaf botany

Cocaine Nation: How the White Trade Took Over the World

Cocaine Nation: How the White Trade Took Over the World
by Thomas Feiling (Author)


An in-depth, narrative study of the cocaine industry—from the fields of Colombia to the streets of New York—as it has never been told before.Cocaine is big business and getting bigger. Governments spend millions on a losing war against it, yet it's still the drug of choice in the West. How did the cocaine economy become so massive? Who keeps it running behind the scenes?

In Cocaine Nation, Tom Feiling travels the trade routes from Colombia via Miami, Kingston and Tijuana to London and New york. he meets Medellin hitmen, U.S. kingpins, Brazilian traffickers, and talks to soldiers and narcotics officers who fight the gangs and cartels. He traces cocaine's progress from legal 'pick-me-up' to luxury product to global commodity, looks at legalization programs in countries such...

corner bottom left corner bottom right
© 2012 BrightSurf.com